nano microneedle patch tirzepatide Transdermal patches as a promising drug delivery system for anti-obesogenic molecules NIDDK Tirzepatide Microneedle Patch –

There have been several clinical trials with various GLP-1 agonists investigating cardiovascular outcomes in patients being treated for type 2 diabetes 10,11,12,13,14,15,16,17,18,19

Specific Effects on LDL Cholesterol Semaglutide has been shown to lower LDL cholesterol levels in individuals with type 2 diabetes and obesity

It does not carry oral, drops, or microdose compounded options, and does not stock Ozempic or Mounjaro

For patients who may benefit from GLP-1based therapies but face cost or availability barriers, it may be valuable to explore whether alternative regulatory mechanisms could help balance safety oversight with broader access